Multinational study of oestrogen and progesterone receptor immunocytochemistry on breast carcinoma fine needle aspirates

Cytopathology

Volumn 24, Issue 1, 2013, Pages 7-20

  Marinšek, Ž P ^a   Nolde, N ^a   Kardum Skelin, I ^b   Nizzoli, R ^c   Onal B ^d   Rezanko, T ^e   Tani, E ^f   Ostovic K T ^g   Vielh, P ^h   Schmitt, F ⁱ   Kocjan, G ^j  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b University of Zagreb   (Croatia)

^c Medical Oncology Division of Parma Hospital   (Italy)

^d Department of Pediatric Surgery   (Turkey)

^e ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g University of Zagreb   (Croatia)

^h INSTITUT GUSTAVE ROUSSY   (France)

ⁱ University of Porto   (Portugal)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

Breast carcinoma; Fine needle aspiration cytology; Hormonal receptors; Immunocytochemistry; Laboratory techniques; Oestrogen receptors; Progesterone receptors; Standardization

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ANTIGEN RETRIEVAL; ARTICLE; ASPIRATION CYTOLOGY; BREAST CARCINOMA; CANCER DIAGNOSIS; CONTROLLED STUDY; CYTOPLASM; FINE NEEDLE ASPIRATION BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REPRODUCIBILITY; SMEAR;

BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; CYTODIAGNOSIS; CYTOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; REAGENT KITS, DIAGNOSTIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; TISSUE FIXATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872683885     PISSN: 09565507     EISSN: 13652303     Source Type: Journal    
DOI: 10.1111/cyt.12024     Document Type: Article

References (27)

1. Fitzgibbons PL, Murphy DA, Hammond MEH, Alfred C, Valenstein PN. Recommendations for validating estrogen and progesterone receptor immunohistochemistry assays. Arch Pathol Lab Med 2010;134:930-5.
2. Hammond MEH, Hayes DF, Dowsett M. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol 2010;28:2784-95.
3. Azavedo E, Baral E, Skoog L. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas. Anticancer Res 1986;6:263-6.
4. Masood S. Use of monoclonal antibody for assessment of estrogen receptor content in fine-needle aspiration biopsy specimen from patients with breast cancer. Arch Pathol Lab Med 1989;113:26-30.
5. Skoog L, Humla S, Isaksson S, Tani E. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human mammary carcinomas. Diagn Cytopathol 1989;6:95-8.
6. Vielh P, Magdelénat H, Mosseri V, Remvikos Y, Di Bonito L. Immunocytochemical determination of estrogen and progesterone receptors on 50 fine-needle samples of breast cancer: a prospective study including biochemical correlation and DNA flow cytometric analysis. Am J Clin Pathol 1992;97:254-61.
7. Schmitt FC, Bento MJ, Amendoeira I. Estimation of estrogen receptor content in fine-needle aspirates from breast cancer using the monoclonal antibody 1D5 and microwave oven processing: correlation with paraffin embedded and frozen sections determinations. Diagn Cytopathol 1995;13:347-51.
8. Hudock JA, Hanau CA, Christen R, Bibbo M. Expression of estrogen and progesterone receptors in cytologic specimens using various fixatives. Diagn Cytopathol 1996;15:78-83.
9. Sauer T, Beraki E, Jebsen PW. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay. Analyt Quant Cytol Histol 1998;20:122-6.
10. Tafjord S, Bøhler PJ, Risberg B, Torlakovic E. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry. Diagn Cytopathol 2002;26:137-41.
11. Zoppi JA, Rotundo AV, Sundbald AS. Correlation of immunocytochemical and immunohistochemical determination of estrogen and progesterone receptors in breast cancer. Acta Cytol 2002;46:337-40.
12. Cano G, Milanezi F, Leitão D et al. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol 2003;29:207-11.
13. Moriki T, Takahashi T, Ueta S, Mitani M, Ichien M. Hormone receptor status and HER2/neu overexpression determined by automated immunostainer on routinely fixed cytological specimens from breast carcinoma: correlation with histologic sections determinations and diagnostic pitfalls. Diagn Cytopathol 2004;30:251-6.
14. Gong Y, Symmans WF, Krishnamurthy S, Patel S, Sneige N. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytological specimens of breast carcinoma. Cancer Cytopathol 2004;102:34-40.
15. Malaviya AA, Chinoy RF, Prabhudesai NM et al. Immunocytochemistry on scrape cytology in breast cancer. Will it unearth the weaker positives?. Acta Cytol 2006;50:284-90.
16. Leung SW, Bedard YC. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast. Am J Clin Pathol 1999;112:50-6.
17. Konofaos P, Kontzoglou K, Georgoulakis J et al. The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors. Surg Oncol 2006;15:257-66.
18. Komatsu K, Nakanishi Y, Seki T et al. Application of liquid-based preparation to fine needle aspiration cytology in breast cancer. Acta Cytol 2008;52:591-6.
19. Nishimura R, Aogi K, Yamamoto T et al. Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens. Virchows Arch 2011;458:153-8.
20. Kuenen-Boumeester V, Timmermans AM, De Brujin EMCA, Henzen-Logmans SC. Immunocytochemical detection of prognostic markers in breast cancer; technical considerations. Cytopathology 1999;10:308-16.
21. Nizzoli R, Bozzetti C, Naldi N et al. Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas. Cancer Cytopathol 2000;90:61-6.
22. Klopčič U, Nolde N, Lamovec J, Luzar B. Correlation between estrogen and progesterone receptor status in fine-needle aspiration biopsies and surgically resected specimens in 74 breast cancer patients. Virchows Arch 2008;452(Suppl 1):S230.
23. Kirbiš I, Maxwell P, Fležar MS, Miller K, Ibrahim M. External quality control for immunocytochemistry on cytology samples: a review of UK NEQUAS ICC (cytology module) results. Cytopathology 2011;22:230-7.
24. Kurtycz DFI, Logrono R, Leopando M, Slattery A, Inhorn SL. Immunocytochemistry controls using cell culture. Diagn Cytopathol 1997;17:74-9.
25. Torlakovic EE, Benerjee D, Pilavdzic D et al.Best practice recommendations for standardization of immunohistochemistry tests. Am J Clin Pathol 2010;133:354-65.
26. Masood S. Estrogen and progesterone receptors in cytology: a comprehensive review. Diagn Cytopathol 1992;8:8475-91.
27. Vielh P. Towards credible immunocytochemical findings. Cytopathology 2011;22:213-4.